TuHURA Biosciences, Inc./NV
HURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498382
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
89
- −1 vs. Q1 2026
- Total value $21M
Superinvestors holding HURA
0
- None of the superinvestors held HURA at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by HURA insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 20224:00 PM ET | Feb 15, 2022 | HOFFMAN ROBERTPresident and CEO | PPurchaseCommon Stock | +55K | $0.469 | +$25.8K | 55K | New position | SEC |
| Dec 9, 2021 | Dec 8, 2021 | Praill Anthony ScottChief Financial Officer | PPurchaseCommon Stock | +28.7K | $0.68 | +$19.52K | 37.19K | +338.2% | SEC |
| Dec 8, 2021 | Dec 6 – Dec 7, 2021 | Zarrabian SaiidHead of Strategic Partnerships | PPurchaseCommon Stock | +50K | $0.6281 | +$31.41K | 55.5K | +909.1% | SEC |
| Nov 24, 2021 | Nov 22, 2021 | Johnson Laura L.Director | PPurchaseCommon Stock | +3K | $0.74 | +$2.22K | 3K | New position | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in HURA at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 2,267,901 | $5.31M | 0.00% | +193,673+9.3% | Added |
| NORTHERN TRUST CORP | 1,621,042 | $3.79M | 0.00% | +1,322,855+443.6% | Added |
| BlackRock, Inc. | 690,088 | $1.61M | 0.00% | −1,760,168−71.8% | Reduced |
| GEODE CAPITAL MANAGEMENT, LLC | 484,219 | $1.13M | 0.00% | −502,703−50.9% | Reduced |
| MILLENNIUM MANAGEMENT LLC | 454,535 | $1.06M | 0.00% | +454,535 | New |